ICOS Corporation (ICOS) Reschedules Shareholder Meeting to January 25, 2007
More News related to ICOS
- ICOS (ICOS) Shareholders Vote to Approve Merger With Eli Lilly (LLY)
- ICOS Corporation (ICOS) Reschedules Shareholder Meeting to January 25, 2007
- ICOS Corporation (ICOS) to Receive $34 Per Share From Eli Lilly (LLY) in Amended Merger Agreement
- ICOS Corporation (ICOS) Provides Update to Earnings for Q4, 2006-07
- Eli Lilly (LLY) CEO Said It Does Not Plan to Raise ICOS Offer
More News related to LLY
- Trading Review for Vivus Inc. Issued by Beacon Equity
- VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests
- New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCI
- Lilly Surpasses United Way 2009 Campaign Goal
- Effient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
More News related to Mergers and Acquisitions
- Green Mountain (GMCR) Will Likely Win Diedrich Coffee (DDRX) Bidding War - Analyst
- SkyPeople (SPU) Acquires Yingkou Trusty Fruits in $3.3M Transaction
- GE (GE) Said to Restart NBC Universal Acquisition Talks -WSJ
- Diedrich Coffee (DDRX) Comments on Green Mountain Coffee Roasters' (GMCR) Revised Offer
- Peet's (PEET) Issues Statement Following News Diedrich (DDRX) Says Green Mountain (GMCR) Revised Offer is 'Superior'
ICOS Corporation (NASDAQ: ICOS) announced that its special meeting of shareholders, held today, was adjourned and has been scheduled to January 25, 2007, to give shareholders time to evaluate and vote on the revised Agreement and Plan of Merger, which was announced yesterday.
The revised Agreement and Plan of Merger provides that Eli Lilly and Company (NYSE: LLY) will acquire all of the outstanding common stock of ICOS for a purchase price of $34 per share in cash, increased from the previous $32 per share. A new proxy statement will be distributed to shareholders that will include a description of the amended agreement, a copy of Merrill Lynch's fairness opinion and related disclosures.
Related Categories
Mergers and AcquisitionsStocks Mentioned
-27.49
+0.10Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
